None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Male and Female subjects in general good health, subjects in the age group 18-40 years, subjects willing to to give written informed consent and agree to come for a regular follow up visit, subjects not participated in a similar investigations in the past two weeks, subjects complaining of hair fall and damage, subjects who are not on crash dieting, subjects who agree to not to change the brand of currently used hair color, dye, treatment etc., if during the study term, subjects willing to refrain from any type of hair treatment like head massage, oil application, perming, etc. during the study duration, subjects with at least of two of following complaints- dry damaged hair, brittle and thin hair, premature greying of hair, scalp related complaints like itching, dandruff or irritation
Exclusion criteria
Exclusion criteria: Subjects who are undergoing hair growth treatment within 3 months before screening into the study. Subjects having any active scalp disease which may interfere in the study. Subjects on treatment for active acne Subjects with history or active phase of malignancy and chemotherapy therefore. Subjects who have history of alcoholism and/ or psychiatric disorder including trichotillomania. Subjects who have had hair transplant. Subjects who take pharmaceutical product which cause hirsutism. Subjects on oral hair growth medications which will compromise the study. Subjects who are pregnant lactating or nursing as established with medical history. Chronic illness which may influence the study. Subjects participating in other similar cosmetic or therapeutic trial within last two weeks Any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in the number of terminal hairs and vellus hairs in the target area of the scalp from baseline to end of study identified by Phototrichograms. Reduction change in the shedding range of the hair in the â??60 Second Hair Comb testâ?? from baseline to end of the study. (Hair strength) Change in folliscopic measurement of hair density and hair diameter (Hair Density), Change in nail growth and satisfaction scale on nail health Timepoint: Baseline, day 30, day 60 and day 90 | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in the Hair Assessment Questionnaire, Improvement in the Modified hair wash test (Brittleness and hair loss after washing), Improvement in quality of hair, VAS- Visual analog scale scalp related complaints like itching, dandruff or irritation (Scalp health),Premature graying, Assessment of tolerability of study drug by assessing adverse events, serious adverse events during the study period, Assessment of Global evaluation of overall improvement in scalp and hair. Timepoint: Baseline, day 30, day 60 and day 90 | — |
Countries
India
Contacts
Mprex Healthcare Pvt. Ltd.